Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Products

  Featured Services

Featured Product
Release & Stability Testing
Catalent Pharma Solutions
Product News
Catalent Launches ADVASEPT™ Lock Delivery Technology
Friday, April 24, 2015
Company announces the expansion of its advanced, aseptic, glass-free injectable platform.

Rentschler Expands European Manufacturing Capabilities
Thursday, April 16, 2015
Companies celebrate handover of 1000th ÄKTAprocess.

A New Test to Simultaneously Detect 22 Respiratory Pathogens
Tuesday, April 07, 2015
Luminex® Corporation launches the NxTAG™ Respiratory Pathogen Panel (RUO) - A closed-tube, flexibly scalable solution for respiratory testing.

Expert System Optimizes Discovery of Drugs
Tuesday, April 07, 2015
Pharmaceutical companies use the expert system IMPACT-F to forecast drug-uptake in humans.

High ThroughputPARP in vivo Pharmacodynamic Assay
Monday, February 23, 2015
AMSBIO has introduced a unique High Throughput PARP in vivo Pharmacodynamic Assay that can be used to monitor the efficacy of poly-ADP-ribose polymerase (PARP) inhibitors on PAR formation in vivo; and to measure drug action on PARP in both in vivo and in vitro settings.

Product NewsProduct News
Scientific News
NIH Launches Largest Clinical Trial Focused on HIV-related Cardiovascular Disease
Clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events.
No Evidence to Change Current Transfusion Practices for Adults
Study found no difference in the primary clinical measure between complex cardiac surgery patients.
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Vaccines target unique mutations in each patient’s tumor.
Repurposed Experimental Cancer Drug Restores Brain Function in Mouse Models
NIH-supported research enables clinical trial to explore treatment for most common form of dementia.
Experimental Ebola Vaccine Safe, Prompts Immune Response
Results from US government-sponsored phase 1 trial of VSV vaccine reported.
Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.
NIH Works to Improve Kidney Health for All
Statement of NIDDK Director Griffin P. Rodgers, M.D., for World Kidney Day 2015.
MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study
Phase 1 study to evaluate the novel oncology immunotherapeutic MOR209/ES414 for prostate cancer.
NIH-supported Clinical Trials to Evaluate Long-acting, Injectable Antiretroviral Drugs
Both trials are expected to be completed in 2017.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters